AHFS Drug Information^®

2020, 2021, 2022, 2023, 2024, 2025 Doody's Core Titles List Selection I 5-Star Rating from Doody's Review Service

AHFS DI is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses. With expanded and revised content supported by more than 97,000 references and incorporating the advice of numerous subject matter experts, AHFS DI helps you protect your patients.

Benefits that are unique to AHFS DI include:

• The only remaining original federal compendium whose authority for establishing accepted medical uses includes the broadest scope of drugs and indications under Medicaid, Medicare Part D, and more.
• The only drug information resource with content developed by a professional editorial and analytical staff of pharmacists for a not-for-profit scientific organization.

2026 Edition Updates

• Clinical perspective sections that include place of therapy discussions and recommendations from therapeutic guidelines
• Expanded coverage of specialty medications used to treat a variety of complex, chronic conditions that often require special handling and administration and may require careful oversight to manage severe adverse effects and dosage adjustments
• Contemporary topics such as biosimilars, novel orphan drugs, and updated vaccine guidance based on recommendations from the CDC’s Advisory Committee on Immunization Practices (ACIP) and other authoritative organizations
• Essential drug information content for patient safety including FDA Medwatch alerts, Standardize4Safety concentrations for IV and oral liquid medications, ISMP recommendations, REMS data, BEERS criteria, boxed warnings, and focused updates based on FDA safety findings